349 related articles for article (PubMed ID: 25157115)
1. Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure.
Vodovar N; Séronde MF; Laribi S; Gayat E; Lassus J; Boukef R; Nouira S; Manivet P; Samuel JL; Logeart D; Ishihara S; Cohen Solal A; Januzzi JL; Richards AM; Launay JM; Mebazaa A;
Eur Heart J; 2014 Dec; 35(48):3434-41. PubMed ID: 25157115
[TBL] [Abstract][Full Text] [Related]
2. Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure.
Takahama H; Takashio S; Nishikimi T; Hayashi T; Nagai-Okatani C; Nakagawa Y; Amaki M; Ohara T; Hasegawa T; Sugano Y; Kanzaki H; Yasuda S; Kangawa K; Minamino N; Anzai T
Int J Cardiol; 2018 May; 258():165-171. PubMed ID: 29544926
[TBL] [Abstract][Full Text] [Related]
3. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
[TBL] [Abstract][Full Text] [Related]
4. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE
J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
6. Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases.
Semenov AG; Tamm NN; Seferian KR; Postnikov AB; Karpova NS; Serebryanaya DV; Koshkina EV; Krasnoselsky MI; Katrukha AG
Clin Chem; 2010 Jul; 56(7):1166-76. PubMed ID: 20489134
[TBL] [Abstract][Full Text] [Related]
7. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.
Noveanu M; Breidthardt T; Potocki M; Reichlin T; Twerenbold R; Uthoff H; Socrates T; Arenja N; Reiter M; Meissner J; Heinisch C; Stalder S; Mueller C
Crit Care; 2011; 15(1):R1. PubMed ID: 21208408
[TBL] [Abstract][Full Text] [Related]
9. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F
J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712
[TBL] [Abstract][Full Text] [Related]
10. [Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure].
Manzano-Fernández S; Januzzi JL; Boronat García M; Bonaque-González JC; Muñoz-Esparza C; Albaladejo-Otón MD; Pastor-Pérez FJ; Pastor P; Valdés M; Pascual-Figal DA
Rev Esp Cardiol; 2011 May; 64(5):365-72. PubMed ID: 21397374
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
Mueller T; Gegenhuber A; Poelz W; Haltmayer M
Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643
[TBL] [Abstract][Full Text] [Related]
12. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
[TBL] [Abstract][Full Text] [Related]
13. [BNP/NT-proBNP: what is the best choice in an emergency laboratory?].
Collin-Chavagnac D; Jacques D; Perrin M; Rabilloud M; Manchon M
Ann Biol Clin (Paris); 2006; 64(3):275-80. PubMed ID: 16698565
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.
Stienen S; Salah K; Moons AH; Bakx AL; van Pol PE; Schroeder-Tanka JM; Voogel AJ; Keijer JT; Kortz RA; Dickhoff C; Meregalli PG; Tijssen JG; Pinto YM; Kok WE
Am Heart J; 2014 Jul; 168(1):30-6. PubMed ID: 24952857
[TBL] [Abstract][Full Text] [Related]
15. Pro-B-type natriuretic peptide is cleaved intracellularly: impact of distance between O-glycosylation and cleavage sites.
Nishikimi T; Nakagawa Y; Minamino N; Ikeda M; Tabei K; Fujishima A; Takayama K; Akimoto K; Yamada C; Nakao K; Minami T; Kuwabara Y; Kinoshita H; Tsutamoto T; Ishimitsu T; Kangawa K; Kuwahara K; Nakao K
Am J Physiol Regul Integr Comp Physiol; 2015 Sep; 309(6):R639-49. PubMed ID: 26136529
[TBL] [Abstract][Full Text] [Related]
16. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
[TBL] [Abstract][Full Text] [Related]
17. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
18. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
Omland T
Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
[TBL] [Abstract][Full Text] [Related]
19. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
[TBL] [Abstract][Full Text] [Related]
20. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
